Consent for transfusion: Is it informed?

Transfusion Medicine Reviews

Volumn 11, Issue 4, 1997, Pages 274-285

  Holland, P V ^a  

^a Sacramento Medical Foundation Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; DESMOPRESSIN; FRESH FROZEN PLASMA;

BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; HUMAN; INFORMED CONSENT; MEDICOLEGAL ASPECT; PATIENT INFORMATION; REVIEW; THROMBOCYTE TRANSFUSION;

EID: 0030721494     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(97)80093-4     Document Type: Article

References (64)

1. Rozovsky FA Consent to treatment: A practical guide 1.12.4 Supplement 1991 4
2. Willett DE The duty to warn about transfusion risks Arch Pathol Lab Med 113 1989 307 310
3. Forward Curran WJ Rozovsky FA ed 2 Consent to Treatment: A Practical Guide 1990 Little, Brown and Co Boston
4. (letter) Ajlouni KM History of informed medical consent Lancet 346 1995 980
5. Meisel A The exceptions to the informed consent doctrine: Striking a balance between competing values in medical decision making Wis Law Rev 1979 413 488
6. Rennie D Informed consent by “well-nigh abject” adults N Engl J Med 302 1980 917 918
7. Drane JF Competency to give an informed consent: A model for making clinical assessments JAMA 252 1984 925 927
8. Blackhall LJ Murphy ST Frank G Ethnicity and attitudes toward patient autonomy JAMA 274 1995 820 825
9. Ingelfinger FJ Informed (but uneducated) consent N Engl J Med 287 1972 465 466
10. Capen K Informed consent and blood transfusion: What does Krever's interim report mean to doctors? Can Med Assoc J 152 1995 1663 1665
11. Piper A Truce on the battlefield: A proposal for a different approach to medical informed consent J Law Med Ethics 22 1994 301 317
12. Curran WJ Law-Medicine Notes. Informed consent in malpractice cases: A turn toward reality N Engl J Med 314 1986 429 431
13. Office of Medical Applications of Research. NIH Perioperative red cell transfusions JAMA 260 1988 2700 2703
14. Office of Medical Applications of Research. NIH Platelet transfusion therapy JAMA 257 1987 1777 1780
15. Office of Medical Applications of Research. NIH Fresh frozen plasma: Indications and risks JAMA 253 1985 551 553
16. Czer LSC Shoemaker WC Optimal hematocrit value in critically ill postoperative patients Surg Gyn Obst 147 1978 363 368
17. Carson JL Poses RM Spence RK Severity of anaemia and operative mortality and morbidity Lancet 1 1988 727 729
18. Carson JL Duff A Poses RM Effect of anaemia and cardiovascular disease on surgical mortality and morbidity Lancet 348 1996 1055 1060
19. Williamson LM Allain JP Virally inactivated fresh frozen plasma Vox Sang 69 1995 159 165
20. Bell WR Braine HG Ness PM Improved survival in thrombotic thrombocytopenic purpura—hemolytic uremic syndrome N Engl J Med 325 1991 398 403
21. Roach GW Kanchuger M Mora Mangaro C Adverse cerebral outcomes after coronary bypass surgery N Engl J Med 335 1996 1857 1863
22. Keeney RL Sounding Board: Decisions about life-threatening risks N Engl J Med 331 1994 193 196
23. Sutter Physician September 15, 1995
24. Goodnough LT Shuck JM Risks, options, and informed consent for blood transfusion in elective surgery Amer J Surg 159 1990 602 609
25. (letter) Schreiber GB Busch MP Kleinman SH Transfusion-transmitted viral infections N Engl J Med 335 1996 1610
26. Texas Medicine Gibson v Methodist Hospital Texas Supreme Court, 1993 89 1993 55 56
27. Harpaz R von Seidlein L Averhoff FM Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control N Engl J Med 334 1996 549 554
28. Esteban JI Gomez J Martell M Transmission of hepatitis C virus by a cardiac surgeon N Engl J Med 334 1996 555 560
29. Allander T Gruber A Naghavi M Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward Lancet 345 1995 603 607
30. Abulrahi HA Bohlega EA Fontaine RE Plasmodium falciparum malaria transmitted in hospital through heparin locks Lancet 349 1997 23 25
31. Classen DC Pestotnik SL Evans RJ Adverse drug events in hospitalized patients: Excess length of stay, extra costs, and attributable mortality JAMA 277 1997 301 306
32. Alter MJ Hadler SC Judson FM Risk factors for acute non-A, non-B hepatitis in the United States and associated hepatitis C virus infection JAMA 264 1990 2231 2235
33. HIV/AIDS surveillance report July 1992 Centers for Disease Control Atlanta, GA
34. Aach RD Lander JJ Sherman LA Transfusion-transmitted viruses: Interim analysis of hepatitis among transfused and non-transfused patients Vyas GN Cohen SN Schmid R Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention 1978 Franklin Institute Press Philadelphia 383 396
35. Seeff LB Wright EC Zimmerman HJ Posttransfusion hepatitis, 1973–1975: A Veterans Administration cooperative study Vyas GN Cohen SN Schmid R Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention 1978 Franklin Institute Press Philadelphia 371 381
36. Haditsch M Binder L Gabriel C Yersinia enterocolitica septicemia in autologous blood transfusion Transfusion 34 1994 907 909
37. Kanter MH van Maanen P Anders KH Preoperative autologous blood donations before elective hysterectomy JAMA 276 1996 798 801
38. Edelman MJ Potter P Mahaffey KA The potential for reintroduction of tumor cells during intraoperative blood salvage: Reduction of risk with use of the RC-400 leukocyte depletion filter Urology 47 1996 179 181
39. Linden JV Paul B Dressler KP A report of 104 transfusion errors in New York State Transfusion 32 1992 601 606
40. (letter) Ohto H Yasuda H Noguchi M Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives Transfusion 32 1992 691 692
41. Busch MP Young MJ Samson SM Risk of human immunodeficiency virus transmission by blood transfusions prior to the implementation of HIV antibody screening in the San Francisco Bay Area Transfusion 31 1991 4 9
42. (letter) Kreimeier U Christ F Kraft D Anaphylaxis due to hydroxyethyl-starch-reactive antibodies Lancet 346 1995 49 50
43. Recalls issued for Centeon products Regulatory Update October 1996
44. (letter) Hartmann S Fatal complication of desmopressin Lancet 346 1995 447
45. Osterborg A Boogaerts MA Cimino R Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma—randomized multicenter study Blood 87 1996 2675 2682
46. (letter) Peces R de la Torre M Alcazar R Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia N Engl J Med 335 1996 523 524
47. Levin J Thrombopoietin—clinically realized? N Engl J Med 336 1997 434 436
48. Fanucchi M Glaspy J Crawford J Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer N Engl J Med 336 1997 404 409
49. Faber-Langedoen K Testimony before FDA Panel on June 6, 1995 CCBC Newsletter June 23, 1995 9
50. Holland PV Schmidt PJ Standards for Blood Banks and Transfusion Services ed 12 1987 AABB Arlington, VA
51. Gostin LO Informed consent, cultural sensitivity, and respect for persons JAMA 274 1995 844 845
52. Informed Consent of Human Subjects Federal Register 46 1981 8951 8952
53. Jensen LS Kissmeyer-Nielsen P Wolff B Randomized comparison of leukocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery Lancet 348 1996 841 845
54. Duke BJ Modin GW Schecter WP Transfusion significantly increases the risk for infection after splenic injury Arch Surg 128 1993 1125 1132
55. Busch OR Hop WC Hoynck van Papendrecht MA Blood transfusions and prognosis in colorectal cancer N Engl J Med 328 1993 1372 1376
56. Blumberg N Heal JM Effects of transfusion on immune function: Cancer recurrence and infection Arch Pathol Lab Med 118 1994 371 379
57. Vignali A Braga M Gianotti L A single unit of transfused allogeneic blood increase postoperative infections Vox Sang 71 1996 170 175
58. Vignali A Braga M Dionigi P Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer Eur J Surg 161 1995 487 492
59. Vamvakas EC Carven JH Hibberd PL Blood transfusion and infection after colorectal cancer surgery Transfusion 36 1996 1000 1008
60. Tartter PI Blood transfusion history in colorectal cancer patients and cancer-free controls Transfusion 28 1988 593 596
61. (letter) Sano H Koga Y Hamasaki K Anaphylaxis associated with white-cell reduction filter Lancet 347 1996 1053
62. Bush RS Jenkin RDT Allt WEC Definitive evidence for hypoxic cells influencing cure in cancer therapy Br J Cancer 37 1978 302 306
63. AuBuchon JP Blood transfusion options: Improving outcomes and reducing costs Arch Pathol Lab Med 121 1997 40 47
64. Wilkes MS Schriger DL Caution: The meter is running—Informing patients about health care costs West J Med 165 1996 74 79